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Methods: 24 skeletally mature New Zealand White rabbits un-
derwent anterior cruciate ligament transection. 6 additional sham
operated animals were used as controls. 10 days after the
surgery the transected animals received an intraarticular injec-
tion of CD-RAP encapsulated in liposomes or liposomes alone
as vehicle control. Three different dose levels of CD-RAP were
tested. Thereafter the animals were injected every 10 days until
the end of the 9-week treatment period. The animals were anal-
ysed macroscopically, radiologically, and histologically. To score
the radiological and histological data, the Kellgren and a modified
Mankin score, respectively, were used.
Results: CD-RAP treatment resulted in reduced osteophyte for-
mation and reduced joint space narrowing. This effect was signif-
icant as shown by the radiological scoring There was a trend to-
wards middle and high dose CD-RAP being more efficacious than
the low dose group but this was not statistically significant. The
histological evaluation by the modified Mankin score, which eval-
uated cartilage structure, cells, matrix (safranin-O), and tidemark
integrity, confirmed the radiological results. The average scores
for sham, vehicle, and treatments groups (low, mid and high dose
CD-RAP) were 1.12±1.19, 7.28±2.19, 7.22±2.69, 4.08±0.8,
4.47±1.93. Both middle and high dose CD-RAP groups showed
a significant improvement over the vehicle group. Looking at the
individual parameters, CD-RAP appeared to impact structural
integrity as well as matrix content.
Conclusions: These data suggest that treatment with the carti-
lage specific protein CD-RAP may be a new therapeutic option
for osteoarthritis patients. Next steps will include the long-term
evaluation of liposome-encapsulated CD-RAP in a large animal
model.
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Purpose: Osteoarthritis is characterized by the progressive de-
struction of articular cartilage. Damage to the collagen network
is often considered irreversible, whereas proteoglycan loss is
reversible. Understanding mechanisms of repair of the collagen
network is therefore key for functional repair of cartilage. The
present study was designed to test whether collagen synthesis
and subsequent crosslinking could be influenced such that a
functional collagen network is formed.
Methods: Bovine articular chondrocytes were cultured in algi-
nate beads for 5 weeks in the presence or absence of the lysyl
oxidase inhibitor BAPN (0.25 mM) followed by 5 weeks without
BAPN (+/- or -/-). Collagen deposition and amout of crosslinks
(HPLC) and gene expression of collagen type 1 and 2 and SOX9
(RT-QPCR) were measured. Susceptibility of the extracellular
matrix to in vitro degradation by MMP-1 was examined after 70
days of culture by overnight incubating 4 alginate beads with
100nM MMP-1. Alginate constructs of 3 mm thick and 6 mm in
diameter were used to determine the equilibrium modulus and
de secant modulus by unconfined compression. Here, an extra
control was added to examine the effect of no crosslinks after 10
weeks of culture with BAPN (+/+).
Results: Complete inhibition of collagen crosslinking for 5 weeks
by BAPN increased the collagen deposition 1.8 times, with a
concomitant increase in tissue stiffness (the equilibrium mod-
ulus increased from 451 Pa to 879 Pa), despite the absence
of crosslinks in the BAPN condition. When after 10 weeks the
amount of collagen is further increased, crosslinks also seem to
be important in improving the stiffness of the matrix. From week 8
onwards, i.e. 3 weeks after removal of the crosslink inhibitor, the
crosslinks returned approaching the level of the control condition
at week 10. With equal amount of crosslinks (-/- and +/-) the
equilibrium modulus is higher when more collagen was present.
However, the total absence of collagen crosslinks together with
more collagen resulted in a lower secant modulus in the +/+ con-
dition, indicating a higher permeability of the matrix. Incubation
of 10-week-old beads in buffer with collagenase MMP-1, lead
to a 2.5 fold increase of collagen release in the supernatant in
the condition without crosslinks (+/+) than in the two conditions
with crosslinks (-/- and +/-). SOX9 expression was not influenced
by addition of BAPN whereas the COL2/COL1 ratio was higher,
indicating that inhibition of crosslinks results in more collagen
without affecting chondrocyte phenotype significantly.
Conclusions: Modulation of the amount of crosslinking and
subsequently collagen deposition, during cartilage tissue regen-
eration has an effect on the functional properties of the construct.
After 5 weeks, more collagen alone led to an increase of stiffness
of the matrix. However, when more collagen was deposited after
10 weeks, crosslinks were also needed to improve matrix stiff-
ness. The quality of the matrix indicated by MMP-1 degradation
susceptibility is not influenced by the transient crosslink inhibi-
tion. These data suggest that modulation of the collagen network
may be a feasible approach to induce cartilage regeneration.
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Purpose: Osteoarthritis is the most prevalent chronic human
disease characterised by a deterioration of cartilage. Despite
its important socio-economical impact, there is, until now, no
satisfactory way to treat the disease. Symptomatic treatment
with antalgics or anti-inflammatory drugs does not stop the
progression of cartilage degeneration, and often presents side-
effects, which limit their chronic use. Our goal is to design new
therapeutic approaches, keeping in mind that cartilage is one of
the rare human tissues which is unable to regenerate. The loss
of matrix components, especially glycosaminoglycans (GAG), is
an early event of cartilage damage.
Methods: An innovative strategy of cartilage bioengineering con-
sists in overexpression by gene transfer, of glycosyltransferases
able to stimulate the anabolic activity of chondrocytes, in or-
der to promote cartilage repair. In that context, the research of
our group is mainly devoted to the identification, cloning and
structural characterisation of key-glycosyltransferases involved
in the biosynthesis of GAG of the cartilage matrix. The work
has been especially focused on the human galactose β 1,3-
glucuronosyltransferase-I (GlcAT-I) which is involved in the final
step of the biosynthesis of the common GAG-protein tetrasac-
charidic linkage sequence, GlcA β1-3Gal β1-3Gal β1-4Xyl-O-.
Results: We have shown that any variation of the GlcAT-I activity
in chondrocytes or cartilage explants, either upon overexpres-
sion, or, in contrast, by repression with antisense RNA, could
increase, or decrease the GAG content in cartilage, respec-
tively. Interestingly, overexpression of this enzyme was able to
completely counteract the proinflammatory cytokine, interleukine
1β-induced depletion of GAG. The neosynthesised GAG were
qualitatively similar to those present in the original cartilage ma-
